Who Owns GH Research Stock?
NASDAQ: GHRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 74.20%
- Held by insiders
- 24.97%
- Institutional holders
- 103
- Institutions 74.2%
- Insiders 25.0%
- Public and other 0.8%
Who owns GH Research stock?
Institutional investors own about 74.2% of GH Research's shares, spread across 103 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 24.97% of GHRS.
The largest institutional holders are Lynx1 Capital Management Lp (19.33%), BVF Inc. (12.61%) and RA Capital Management, L.P. (11.13%). Together, the top 10 institutions control 71.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their GHRS positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GHRS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Lynx1 Capital Management Lp | 13.26M | 19.33% | +23.2% |
| BVF Inc. | 8.65M | 12.61% | 0.0% |
| RA Capital Management, L.P. | 7.64M | 11.13% | -0.5% |
| FMR, LLC | 6.48M | 9.45% | +8.5% |
| RTW Investments LP | 5.93M | 8.65% | 0.0% |
| Deep Track Capital, Lp | 3.33M | 4.86% | +100.0% |
| Avoro Capital Advisors LLC | 1.80M | 2.62% | 0.0% |
| Foresite Capital Management VI LLC | 940.49K | 1.37% | +198.1% |
| Siren, L.L.C. | 600.00K | 0.87% | +100.0% |
| Blackrock Inc. | 529.08K | 0.77% | +10.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GHRS
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.10M | 3.07% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 637.54K | 0.93% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 493.50K | 0.72% |
| iShares Trust-iShares Biotechnology ETF | 397.10K | 0.58% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 178.40K | 0.26% |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 92.04K | 0.13% |
| iShares Trust-iShares MSCI Ireland ETF | 52.76K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 40.48K | 0.06% |
| ETFis Series Trust I-Virtus Biotech Clinical Trials ETF | 14.72K | 0.02% |
| BNY Mellon Funds Trust-BNY Mellon Small Cap Multi-Strategy Fund | 11.67K | 0.02% |
Frequently asked questions
Who is the largest shareholder of GH Research?
Lynx1 Capital Management Lp is the largest institutional shareholder of GHRS, owning 19.33% of shares outstanding (13.26M shares) as of its latest 13F filing.
What percentage of GH Research is owned by institutions?
Institutions own about 74.2% of GHRS shares and 98.9% of the public float.
How much of GH Research do insiders own?
Insiders, such as officers and directors, own about 24.97% of GHRS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.